Ruud. H. Brakenhoff

Ruud. H. Brakenhoff's AcademicInfluence.com Rankings

Ruud. H. Brakenhoff

Biology

#12257

World Rank

#15721

Historical Rank

Molecular Biology

#1970

World Rank

#2002

Historical Rank

biology Degrees

Download Badge

Biology

Ruud. H. Brakenhoff's Degrees

Masters Biology University of Amsterdam

Similar Degrees You Can Earn

Best Online Master's in Biology

Why Is Ruud. H. Brakenhoff Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ruud. H. Brakenhoff's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The molecular biology of head and neck cancer (2011) (1336)
Dissecting the metastatic cascade (2004) (1290)
A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. (2003) (1202)
Detection, clinical relevance and specific biological properties of disseminating tumour cells (2008) (1099)
A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen (2007) (758)
The molecular landscape of head and neck cancer (2018) (708)
Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. (2004) (430)
Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas (2001) (327)
Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. (2001) (326)
Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus (2006) (265)
Second primary tumors and field cancerization in oral and oropharyngeal cancer: Molecular techniques provide new insights and definitions (2002) (252)
Molecular signature associated with bone marrow micrometastasis in human breast cancer. (2003) (239)
BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH) (2006) (220)
Multiple head and neck tumors frequently originate from a single preneoplastic lesion. (2002) (220)
Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm (2013) (204)
A genetic progression model of oral cancer: current evidence and clinical implications. (2004) (190)
Genetically Altered Fields as Origin of Locally Recurrent Head and Neck Cancer (2004) (172)
Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. (2013) (166)
Mutated p53 as a molecular marker for the diagnosis of head and neck cancer (2002) (165)
Molecular Diagnosis of Surgical Margins and Local Recurrence in Head and Neck Cancer Patients (2004) (164)
Wait‐and‐see policy for the N0 neck in early‐stage oral and oropharyngeal squamous cell carcinoma using ultrasonography‐guided cytology: Is there a role for identification of the sentinel node? (2002) (146)
Down-Regulated Expression of Cytokeratin 18 Promotes Progression of Human Breast Cancer (2004) (138)
Advances and applications of oral cancer basic research. (2011) (134)
Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx (2003) (130)
Early diagnosis in primary oral cancer: is it possible? (2011) (129)
Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. (2002) (120)
Molecular characterization of p16‐immunopositive but HPV DNA‐negative oropharyngeal carcinomas (2014) (117)
Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients. (2008) (110)
Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing (2018) (108)
Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways (2011) (103)
Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. (2005) (98)
Genomic Profiles Associated with Early Micrometastasis in Lung Cancer: Relevance of 4q Deletion (2009) (95)
Second field tumors: a new opportunity for cancer prevention? (2005) (93)
Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study (2018) (91)
Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis (2015) (90)
Molecular analysis of surgical margins in head and neck cancer: more than a marginal issue. (2010) (89)
Human papilloma virus in head and neck cancer: the need for a standardised assay to assess the full clinical importance. (2009) (89)
Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990–2009) (2014) (88)
Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure. (2003) (86)
Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients. (2005) (84)
Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients. (1997) (83)
A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma (2018) (81)
Chimeric cDNA clones: a novel PCR artifact. (1991) (78)
Activation of the ΓE-crystallin pseudogene in the human hereditary Coppock-like cataract (1994) (78)
Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer. (2014) (78)
Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma. (2012) (76)
Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors. (2012) (75)
Genetic Classification of Oral and Oropharyngeal Carcinomas Identifies Subgroups with a Different Prognosis (2009) (75)
Prognostic Significance of Truncating TP53 Mutations in Head and Neck Squamous Cell Carcinoma (2011) (75)
Protein biomarker discovery for head and neck cancer. (2010) (75)
Human γ-crystallin genes: A gene family on its way to extinction (1990) (72)
Characterization of the human Ly‐6 antigens, the newly annotated member Ly‐6K included, as molecular markers for head‐and‐neck squamous cell carcinoma (2003) (72)
Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck (2009) (67)
Functional Genetic Screens Identify Genes Essential for Tumor Cell Survival in Head and Neck and Lung Cancer (2013) (67)
Genome-wide microarray gene expression, array-CGH analysis, and telomerase activity in advanced ovarian endometriosis: a high degree of differentiation rather than malignant potential. (2008) (67)
Differential Proteomics Identifies Protein Biomarkers That Predict Local Relapse of Head and Neck Squamous Cell Carcinomas (2009) (66)
Assessment and Clinical Significance of Micrometastases in Lymph Nodes of Head and Neck Cancer Patients Detected by E48 (Ly-6D) Quantitative Reverse Transcription-Polymerase Chain Reaction (2003) (66)
Minimal Residual Disease in Head and Neck Cancer (2004) (64)
Prognostic value of DNA ploidy status in patients with oral leukoplakia. (2011) (63)
Outcome of patients with early stage oral cancer managed by an observation strategy towards the N0 neck using ultrasound guided fine needle aspiration cytology: No survival difference as compared to elective neck dissection. (2013) (63)
Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging. (2014) (63)
Circulating invariant natural killer T-cell numbers predict outcome in head and neck squamous cell carcinoma: updated analysis with 10-year follow-up. (2012) (62)
Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia. (2010) (60)
Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction. (1999) (59)
Molecular screening of oral precancer. (2013) (58)
A noninvasive genetic screening test to detect oral preneoplastic lesions (2005) (58)
Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma (2011) (58)
Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines. (2013) (57)
Microarray techniques in pathology: tool or toy? (2000) (54)
Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene (2002) (54)
Clinical Significance of Micrometastatic Cells Detected by E48 (Ly-6D) Reverse Transcription-Polymerase Chain Reaction in Bone Marrow of Head and Neck Cancer Patients (2004) (54)
Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinoma. (2012) (54)
Defective sister chromatid cohesion is synthetically lethal with impaired APC/C function (2015) (51)
Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications. (2007) (50)
Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma (2006) (50)
Characterization of cd44v6 isoforms in head‐and‐neck squamous‐cell carcinoma (1999) (49)
Head and neck squamous cell carcinoma: US-guided fine-needle aspiration of sentinel lymph nodes for improved staging--initial experience. (2001) (49)
Genetic reprogramming of tumor cells by zinc finger transcription factors. (2005) (48)
Prevalence of human papillomavirus in laryngeal and hypopharyngeal squamous cell carcinomas in northern Spain. (2015) (48)
Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma (2005) (47)
No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors. (2014) (47)
CGHMultiArray: exact P-values for multi-array comparative genomic hybridization data (2005) (47)
CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties. (2013) (45)
Screening for Oral Precancer with Noninvasive Genetic Cytology (2009) (44)
Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous‐cell carcinoma, recognizes a CD44 isoform (1996) (42)
DPHL: A DIA Pan-human Protein Mass Spectrometry Library for Robust Biomarker Discovery (2020) (40)
Comparative evaluation of genetic assays to identify oral pre-cancerous fields. (2008) (39)
Perspectives of combined radioimmunotherapy and anti‐EGFR antibody therapy for the treatment of residual head and neck cancer (1998) (39)
Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death (2019) (39)
Human Ly‐6 antigen E48 (Ly‐6D) regulates important interaction parameters between endothelial cells and head‐and‐neck squamous carcinoma cells (2002) (39)
Using tissue adjacent to carcinoma as a normal control: an obvious but questionable practice (2004) (38)
Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma. (1999) (38)
Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates. (2003) (38)
Considerations for in vitro retinoid experiments: importance of protein interaction. (1999) (38)
ACE: absolute copy number estimation from low-coverage whole-genome sequencing data (2019) (37)
DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells (2013) (36)
DNA Quality Assessment for Array CGH by Isothermal Whole Genome Amplification (2007) (36)
Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank (2019) (36)
Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe (2015) (34)
Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC (2015) (34)
Microarray Analysis of Bleomycin-Exposed Lymphoblastoid Cells for Identifying Cancer Susceptibility Genes (2006) (34)
Lymphoscintigraphy and ultrasound-guided fine needle aspiration cytology of sentinel lymph nodes in head and neck cancer patients. (2000) (33)
Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines (2001) (33)
Integration of high‐risk human papillomavirus into cellular cancer‐related genes in head and neck cancer cell lines (2017) (32)
The GPI-linked Ly-6 Antigen E48 Regulates Expression Levels of the FX Enzyme and of E-selectin Ligands on Head and Neck Squamous Carcinoma Cells* (2000) (32)
TP53 mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients. (2014) (32)
High-Risk Human Papillomavirus–Positive Lung Cancer: Molecular Evidence for a Pattern of Pulmonary Metastasis (2013) (30)
Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures (2020) (30)
Human gamma-crystallin genes. A gene family on its way to extinction. (1990) (29)
Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer. (2015) (29)
Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer (2020) (28)
Another NOTCH for Cancer (2011) (26)
Molecular events in relapsed oral squamous cell carcinoma: Recurrence vs. secondary primary tumor. (2015) (26)
Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data. (2016) (26)
Intensity-based analysis of dual-color gene expression data as an alternative to ratio-based analysis to enhance reproducibility (2010) (24)
The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma (2021) (24)
Gene expression profiling in head and neck squamous cell carcinoma (2010) (24)
Direct assignment of the human βB2 and βB3 crystallin genes to 22q11.2→q12: markers for neurofibromatosis 2 (1991) (24)
To DNA or not to DNA? That Is the Question, When It Comes to Molecular Subtyping for the Clinic! (2011) (24)
HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs? (2015) (24)
Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression (2020) (23)
Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells (2001) (23)
The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics (2016) (23)
Biomarkers predicting malignant progression of laryngeal epithelial precursor lesions: a systematic review (2012) (22)
Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy (2020) (22)
Prognostic modeling of oral cancer by gene profiles and clinicopathological co-variables (2017) (22)
Activation of the gamma E-crystallin pseudogene in the human hereditary Coppock-like cataract. (1994) (22)
Protein signatures associated with tumor cell dissemination in head and neck cancer. (2011) (21)
Enhanced turnover of all-trans-retinoic acid and increased formation of polar metabolites in head and neck squamous cell carcinoma lines compared with normal oral keratinocytes. (2001) (21)
Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines. (1997) (21)
Head and neck cancer: molecular carcinogenesis. (2005) (21)
Interaction of quantitative 18F‐FDG‐PET‐CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma (2016) (21)
Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation (2020) (20)
Transgenic Xenopus laevis tadpoles: a transient in vivo model system for the manipulation of lens function and lens development. (1991) (20)
Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining (2018) (20)
The second human βB2-crystallin gene is a pseudogene (1992) (20)
Molecular Patterns and Biology of HPV-Associated HNSCC. (2017) (20)
Epidemiologic associations of HPV‐positive oropharyngeal cancer and (pre)cancerous cervical lesions (2018) (20)
Comprehensive multiparameter genetic analysis improves circulating tumor DNA detection in head and neck cancer patients. (2020) (18)
Current potential and limitations of molecular diagnostic methods in head and neck cancer (2010) (18)
Adenovirus retargeting to surface expressed antigens on oral mucosa (2010) (18)
Noninvasive Molecular Screening for Oral Precancer in Fanconi Anemia Patients (2015) (17)
Rapid elimination of mouse/human chimeric monoclonal antibodies in nude mice (1997) (17)
Differential Diagnosis of Pulmonary Carcinoma Following Head and Neck Cancer by Genetic Analysis (2009) (16)
Molecular Detection of Minimal Residual Cancer in Surgical Margins of Head and Neck Cancer Patients (2009) (16)
Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors (2020) (16)
Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer (1995) (16)
Improved high-dimensional prediction with Random Forests by the use of co-data (2017) (15)
Molecular diagnosis of minimal residual disease in head and neck cancer patients (2012) (15)
A gain of novel tissue specificity in the human Ly-6 gene E48. (1997) (15)
Exfoliated oral cell messenger RNA: suitability for biomarker studies. (1998) (15)
Quantitative Diffusion-Weighted MRI Parameters and Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma (2015) (15)
Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass. (2019) (15)
Abstract 338: Truncating TP53 mutations have prognostic significance in head and neck squamous cell carcinoma (2011) (14)
Identification of Lethal microRNAs Specific for Head and Neck Cancer (2013) (14)
Publisher Correction: The molecular landscape of head and neck cancer (2018) (14)
Human lymphoblastoid proteome analysis reveals a role for the inhibitor of acetyltransferases complex in DNA double-strand break response. (2006) (14)
Re: Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. (2004) (13)
Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck. (2017) (13)
Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy (2019) (13)
All-trans retinoic acid induced gene expression and growth inhibition in head and neck cancer cell lines. (1997) (12)
Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction. (2019) (12)
No Evidence for FANCF Gene Silencing in Head-and-Neck Squamous Cell Carcinomas (2008) (12)
A comprehensive assessment protocol including patient reported outcomes, physical tests, and biological sampling in newly diagnosed patients with head and neck cancer: is it feasible? (2014) (12)
Sequence variation in the monoclonal-antibody-U36-defined CD44v6 epitope (1997) (12)
Biologic implications of genetic changes in head and neck squamous cell carcinogenesis. (1997) (12)
Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study. (2020) (12)
Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selection (2018) (12)
Generation of precursor cell lines from preneoplastic fields surrounding head and neck cancers (2013) (12)
Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy. (2020) (11)
Drug sensitivity prediction models reveal a link between DNA repair defects and poor prognosis in HNSCC. (2019) (11)
Response to correspondence on the molecular biology of head and neck cancer (2011) (11)
Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer Patients (2019) (11)
Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art (2016) (11)
Human αB-crystallin (CRYA2) gene mapped to chromosome 11q12-q23 (1990) (10)
The course of health-related quality of life from diagnosis to two years follow-up in patients with oropharyngeal cancer: does HPV status matter? (2021) (10)
Expression signature in peripheral blood cells for molecular diagnosis of head and neck squamous cell carcinoma. (2013) (10)
Comparative proteome analysis to explore p53 pathway disruption in head and neck carcinogenesis. (2009) (10)
Resection Margins in Head and Neck Cancer Surgery: An Update of Residual Disease and Field Cancerization (2021) (10)
Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project (2020) (9)
Comparison of oncolytic adenoviruses for selective eradication of oral cancer and pre-cancerous lesions (2010) (9)
A Prospectively Validated Prognostic Model for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck Based on Radiomics of Computed Tomography Images (2021) (8)
Detection and localization of early- and late-stage cancers using platelet RNA. (2022) (8)
The second human beta B2-crystallin gene is a pseudogene. (1992) (8)
The feasibility of radioimmunotherapy of head and neck cancer. (1994) (7)
Nonmalignant Oral Keratinocytes from Patients with Head and Neck Squamous Cell Carcinoma Show Enhanced Metabolism of Retinoic Acid (2002) (7)
Study retention and attrition in a longitudinal cohort study including patient-reported outcomes, fieldwork and biobank samples: results of the Netherlands quality of life and Biomedical cohort study (NET-QUBIC) among 739 head and neck cancer patients and 262 informal caregivers (2022) (7)
Limited detection of human polyomaviruses in Fanconi anemia related squamous cell carcinoma (2018) (7)
Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck (2017) (6)
Unmet Needs and Perspectives in Oral Cancer Prevention (2022) (6)
Development and validation of a novel and rapid molecular detection method for high-risk HPV in formalin-fixed paraffin-embedded tumor tissue. (2019) (6)
Corrigendum to "Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging" [Radiother Oncol 113 (2014) 324-30]. (2017) (6)
Direct assignment of the human beta B2 and beta B3 crystallin genes to 22q11.2----q12: markers for neurofibromatosis 2. (1991) (6)
Human alpha B-crystallin (CRYA2) gene mapped to chromosome 11q12-q23. (1990) (5)
Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition (2020) (5)
Ovarian cancer‐derived copy number alterations signatures are prognostic in chemoradiotherapy‐treated head and neck squamous cell carcinoma (2020) (5)
Calendar of Events: 1991 — 1992 (1991) (4)
Complete ablation of small squamous cell carcinoma xenografts with186Re-labeled monoclonal antibody E48 (2007) (4)
911O Performance of dual p16 and HPV testing for determining prognosis in cancer of the oropharynx, the EPIC-OPC Study (2020) (4)
Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications (2021) (4)
Secreted protein markers in oral squamous cell carcinoma (OSCC) (2021) (4)
Associations between clinical and histopathological characteristics in oral leukoplakia (2021) (3)
At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma (2021) (3)
The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysis. (2021) (3)
PD.66 A non-invasive genetic screening test to detect oral preneoplastic lesions (2005) (3)
Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus–Positive Oropharyngeal Carcinoma (2021) (3)
Sensitivity to chromosomal breakage as risk factor in young adults with oral squamous cell carcinoma. (2016) (3)
Correction: Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy (2020) (3)
Expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer. (2020) (3)
Survival in Head and Neck and Lung Cancer Functional Genetic Screens Identify Genes Essential for Tumor Cell (2013) (2)
Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer. (2022) (2)
A device for quantitative measurement of the opacity of small animal lenses: application to Xenopus laevis. (1992) (2)
NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models (2021) (2)
tigaR: integrative significance analysis of temporal differential gene expression induced by genomic abnormalities (2014) (2)
Potentially novel options for treatment of HPV-attributable head and neck cancer (2013) (2)
Ultrasound guided fine needle aspiration cytology of sentinel lymph nodes in head and neck cancer patients (1999) (2)
Oral cancer prediction by noninvasive genetic screening (2022) (2)
PV-0312 Distributed learning in radiomics to predict overall survival in head and neck cancer (2019) (1)
OC-0373: An HPV-based predictive model for oropharynx cancer yields more accurate predictions than TNM staging system (2014) (1)
Discovery of Salivary Gland Tumors' Biomarkers via Co-Regularized Sparse-Group Lasso (2017) (1)
Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis. (2023) (1)
Assessing the prognostic value of tumor-infiltrating CD57+ cells in advanced stage head and neck cancer using QuPath digital image analysis (2022) (1)
Correction to: Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank (2019) (1)
Quantitative Diffusion-WeightedMRI Parameters and Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma (2015) (1)
Age-group-specific trend analyses of oropharyngeal squamous cell carcinoma incidence from 1989 to 2018 and risk factors profile by age-group in 2015–2018: a population-based study in The Netherlands (2021) (1)
Abstract 5100: Secretome proteomics to identify indicators for lung cancer treatment response prediction and monitoring (2011) (1)
A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma (2018) (1)
Improved high-dimensional prediction with Random Forests by the use of co-data (2017) (1)
tigaR: integrative significance analysis of temporal differential gene expression induced by genomic abnormalities (2014) (1)
DNA quality assessment and amplification for array CGH (2007) (1)
Genetic characterization of HNSCC of young adults (2011) (0)
Identification of genes relevant to occult bone marrow micrometastasis in human breast cancer using gene expression profiling (2002) (0)
The Genomic Landscape of HNSCC (2018) (0)
Targeted radiotherapy of squamous head and neck cancer (2000) (0)
Oral cancers expressing Glycoprotein-A repetitions predominant (GARP) show poor prognosis (2019) (0)
S 319 DIRECT GENETIC ANALYSIS OF SINGLE HEAD AND NECK SQUAMOUS CELL CARCINOMA ( HNSCC ) CELLS ISOLATED FROM PRIMARY TUMORS AND MATCHED NODAL METASTASES (2014) (0)
Chapter 5 Identiiication of Lethal Micrornas Speciiic for Head and Neck Cancer (2014) (0)
Abstract 1750: Identification of genes involved in chemoradiation response of head and neck cancer by functional genetic screens (2011) (0)
Fanconi anemia: course of disease in the Dutch patient cohort and early recognition of cancer (2013) (0)
Publisher Correction: The molecular landscape of head and neck cancer (2018) (0)
Abstract 4823: Single cell analysis of head and neck squamous cell carcinoma cells isolated from primary tumors and matched metastases (2011) (0)
Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selection (2018) (0)
Molecular markers for the early detection of second primary tumors (SPT) in head and neck squamous cell carcinoma (HNSCC) patients (2007) (0)
' s response to reviews Title : Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck (2008) (0)
Novel candidate biomarkers for cisplatin response prediction and monitoring in NSCLC (2013) (0)
Oncogenomics/Proteomics of Head and Neck Cancer (2018) (0)
214P Location matters: Oral cancer cells at the tumor invasive border that express GARP exclude immune cells (2022) (0)
Combining coherent imaging and nonlinear microscopy for early-stage cancer detection (2009) (0)
Abstract 4637: Chk1 inhibition: a promising targeted treatment for head and neck squamous cell carcinoma (2016) (0)
P215 TP53 mutations are associated with a particular pattern of genomic imbalances in head and neck squamous cell carcinoma (2007) (0)
Correction to: Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank (2019) (0)
Head and Neck Squamous Cell Carcinoma Mutations in TP 53 Prognostic Significance of Truncating (2011) (0)
Molecular diagnosis of lymph node metastasis in primary head and neck squamous cell carcinoma (2013) (0)
Abstract 4638: Targeted therapy of precancerous fields in the mucosal linings of the head and neck (2016) (0)
High sensitivity to DNA damage in the aetiology of head and neck squamous cell carcinoma in young adults and individuals not exposed to tobacco smoke and excessive alcohol (SenseDNA) (2013) (0)
In Vitro CRISPR-Cas12a-Based Detection of Cancer-Associated TP53 Hotspot Mutations Beyond the crRNA Seed Region (2023) (0)
Development of laser-based imaging systems for medical diagnostics (2009) (0)
935 Attraction of immune cells by head and neck cancer cell lines and primary tumor-conditioned supernatants (2021) (0)
P-79 Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy (2021) (0)
RNA/DNA Based Detection of Minimal Residual Head and Neck Cancer (2003) (0)
A genome-wide siRNA screen identi ies the FA / BRCA pathway as the strongest predictor of cisplatin response in head and neck cancer cells (2014) (0)
Molecular diagnosis of minimal residual disease in head and neck cancer patients (2012) (0)
Molecular analysis of the surgical margins (2007) (0)
Oncogenetics, molecular diagnosis and virotherapy (2007) (0)
Genomic Adjusted Radiation Dose (GARD) Predicts Overall Survival and Outperforms AJCC 8th Edition in Prognostication of HPV-Positive Oropharyngeal Squamous Cell Carcinoma (2022) (0)
SP-014: How to Detect and Use HPV Status? (2013) (0)
12 Invited lecture: High-throughput functional genomics – An emerging field in head and neck cancer research (2015) (0)
O34 An in vitro model of human oral squamous cells for the identification of new cancer genes (2007) (0)
Genes causing head and neck cancer (2005) (0)
[Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression]. (2021) (0)
889 DuoBody®-CD3x5T4 induces efficient T-cell activation and killing of patient-derived head and neck cancer cells in vitro and ex vivo (2021) (0)
Genome-wide siRNA screens identify RBBP9 function as a potential target in Fanconi anaemia-deficient head-and-neck squamous cell carcinoma (2023) (0)
P195 Pulmonary Carcinoma Following Head and Neck Squamous Cell Carcinoma: Differentiation of Metastasis and Second Primary Tumors Using Loss of Heterozygosity and TP53 Analysis (2006) (0)
Targeted therapy of precancerous fields in head and neck mucosa (2013) (0)
Abstract 4122: Multi-center validation of a lymph node metastasis gene-expression signature for head and neck squamous cell carcinomas (2011) (0)
Psychoneurological Symptoms and Biomarkers of Stress and Inflammation in Newly Diagnosed Head and Neck Cancer Patients: A Network Analysis (2022) (0)
641. Retargeting Adenoviruses to Surface Expressed Antigens on Oral Mucosa (2006) (0)
Determinants of chemotherapy sensitivity (2013) (0)
Prevention and therapy of tumors (2002) (0)
Risk Groups for Survival in HPV-Positive and HPV-Negative OPSCC. (2017) (0)
Subject Index Vol. 56, 1991 (1991) (0)
Development of virotherapy using retargeted adenoviruses to eradicate preneoplastic lesions of the oral cavity and oropharynx (2011) (0)
Truncating TP53 mutations in HNSCC (2011) (0)
Sister chromatid cohesion as a novel foothold for cancer therapy (2010) (0)
41 Is HPV infection the first genetic hit in head and neck cancer (2015) (0)
Fanconi anemia-isogenic head and neck cancer cell line pairs - a basic and translational science resource (2022) (0)
OP203: Novel diagnostic modalities for the clinically node-negative neck in oral squamous cell carcinoma (2013) (0)
OC-0642 A radiomics based prognostic model for patients with head and neck squamous cell carcinoma (2021) (0)
Elucidating the genetic landscape of oral leukoplakia to predict malignant transformation. (2022) (0)
CHAPTER 4 Circulating Invariant Natural Killer T-Cell Numbers Predict Outcome in Head and Neck Squamous Cell Carcinoma : Updated Analysis With 10-Year Follow-Up (2015) (0)
Radiation modulates expression and related activities of c-Met protein in oral tongue squamous cell carcinoma cell lines (2022) (0)
The human Ly-6 antigens: suitable targets for diagnosis and (immuno)therapy of squamous cell carcinoma (2007) (0)
Title Page / Table of Contents / Abstracts (1991) (0)
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification (2022) (0)
Structure of lens proteins: a molecular genetic approach (1992) (0)
Oral Leukoplakia Classification and Staging System with Incorporation of Differentiated Dysplasia. (2022) (0)
Molecular basis of key mechanisms in diabetic retinopathy: vascular leakage, basement membrane thickening and fibrovascular proliferation (2006) (0)
Identification of oncogenic microRNAs and cancer genes involved in head and neck squamous cell carcinoma by a functional genomics approach (2013) (0)
SP-001 New insights into the molecular landscape of Head and Neck cancer (2019) (0)
50 INVITED Human papillomavirus infection in head and neck squamous cell carcinoma: another route to cancer (2007) (0)
Preventie en therapie van tumoren (2002) (0)
O165 Retargeting adenoviruses to surface expressed antigens on oral mucosa (2007) (0)
6 CD98 identifies a clinically relevant subpopulation of head and neck squamous cell carcinoma cells with stem cell properties (2015) (0)
Determinants of radio and EGFR-mediated therapy sensitivity (2008) (0)
Cancer Therapy : Preclinical Identi fi cation of Lethal microRNAs Speci fi c for Head and Neck Cancer (2013) (0)
Detection of minimal residual disease in head and neck cancer patients using tumor-specific and tumor-associated markers (2007) (0)
O55 Genome-wide screening of head and neck squamous cell carcinoma (HNSCC) using single nucleotide polymorphic marker (SNP)-arrays (2007) (0)
Correspondence re: M. P. Rosin et al., 3p14 and 9p21 Loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res., 62: 6447-6450, 2002. (2003) (0)
P157 Molecular staging of surgically treated head and neck cancer patients: towards rationalized postoperative clinical management (2007) (0)
P193 Screening for precursor lesions in the oral cavity (2007) (0)
Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition (2020) (0)
89 speaker UNDERSTANDING AND TAKING ADVANTAGE OF THE TUMOR BIOLOGY (2011) (0)
Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer (2020) (0)
Circulating RNAs as biomarkers in Epstein-Barr virus-associated nasopharyngeal carcinoma (2016) (0)
Abstract 2488: Novel candidate protein biomarkers for cisplatin response prediction in non-small cell lung cancer. (2013) (0)
P-186 Neoadjuvant immune checkpoint inhibition in stage III/IV oral cancer patients: the NeoNivo trial (2021) (0)
OP028: A modified prognostic model for oropharyngeal squamous cell carcinoma based on presence of human papillomavirus, nodal stage and comorbidity (2013) (0)
Oncotype DX Test on Unequivocally HER2-Positive Cases: Potential for Harm (2012) (0)
33 Cetuximab paying toll to improve its therapeutic efficacy – Improving cetuximab-mediated head and neck cancer treatment via co-activation of Fc-receptors and toll-like receptors (2015) (0)
A Clinically Translatable Immune-based Classification of HPV-associated Head and Neck Cancer with Implications for Biomarker-Driven Treatment Deintensification and Immunotherapy (2022) (0)
Secreted protein markers in oral squamous cell carcinoma (OSCC) (2022) (0)
CHAPTER Chromatid cohesion defects in human cancer cell lines 6 (2010) (0)
Improving molecular staging of surgically treated head and neck cancer patients: towards rationalized adjuvant treatment (2013) (0)
Clinical significance of human papillomavirus infection in oropharyngeal squamous cell carcinoma (2010) (0)
Improved tumor cell detection by molecular genetic markers in ultrasound guided fine needle aspirates from sentinel cervical lymph nodes of head and neck cancer patients (1999) (0)
Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank (2019) (0)
13 No molecular evidence for the role of the genetic background of the host in explaining lymph node metastasis in head and neck cancer (2015) (0)
CHAPTER 6 Comparison of oncolytic adenoviruses for selective eradication of oral cancer and precancerous lesions (2010) (0)
Genomics features (GF) and integration with MRI radiomics features (RF) to develop a prognostic model in oral cavity squamous cell carcinoma (OSCC). (2018) (0)
Functional characterization of TP53 mutations in head and neck squamous cell carcinoma, and association with clinical outcome (2013) (0)
Molecular diagnosis and genomics-based staging of head and neck cancer (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ruud. H. Brakenhoff?

Ruud. H. Brakenhoff is affiliated with the following schools:

Ruud. H. Brakenhoff's Academic­Influence.com Rankings